CO-FOUNDER, PRESIDENT & CEO

Business development and commercialization executive in biologics with over 25 years in the Neuroscience space, with Allergan, Biogen and Merz Neurosciences.

CO-FOUNDER & CHIEF SCIENTIFIC OFFICER

Accomplished scientific leader in antibody and VHH/nanobody therapeutic development with senior roles at Pfizer, Bristol Myers Squibb, and Denali Therapeutics, where she led antibody discovery for CNS targets.

SCIENTIFIC ADVISOR

Professor Emeritus at the Vrije Universiteit Brussel (VUB), is internationally recognized for discovering the heavy-chain-only antibody system in camelids and for co-inventing the Nanobody® platform that led to the creation of Ablynx

SCIENTIFIC ADVISOR

Professor of Neurology at Stanford University, is an internationally recognized stroke neurologist and clinical trial expert, known for his work in neuroimaging, translational neuroscience, and advancing therapies to improve functional recovery after stroke.

SCIENTIFIC ADVISOR

One of Germany’s foremost neuroscientists. Professor of Neurobiology at Braunschweig Technical University and head of the Neuroinflammation and Neurodegeneration research group at the Helmholtz Centre for Infection Research in Braunschweig.

Co-Founder, President & CEO | Board Member

Seasoned biotechnology executive with deep expertise in neuroscience commercialization and strategic partnerships. Glenn has led Synap’s vision to advance intranasal nanobody therapies and brings extensive experience from leadership roles at Allergan, Biogen, and Merz Neurosciences, guiding the company’s growth, funding strategy, and market positioning.

Co-Founder & Chief Scientific Officer | Board Member

Industry-recognized antibody and nanobody drug development leader with a strong track record in CNS therapeutic discovery. Pallavi provides scientific and strategic oversight at the Board level, shaping Synap’s R&D direction and advancing a multi-target approach to unlocking neuroregeneration.

BOARD MEMBER

Experienced life sciences entrepreneur and executive with a background in drug delivery systems and medical device innovation. Brent brings operational leadership, capital formation experience, and strategic insight to Synap, supporting the company’s development pathway and investor engagement.

Co-Founder | Scientific Advisory Board & Board Member

Co-founder of Synap Biotech with early contributions to the company’s formation and scientific direction. Nicholas continues to provide strategic and scientific perspective through his advisory role, supporting long-term innovation and platform development.

BOARD ADVISOR

Senior life sciences executive with extensive experience in commercialization, market access, and business strategy. Mel provides trusted guidance on corporate development, investor positioning, and strategic partnerships, helping to align Synap’s innovation with real-world market opportunities.